Signature Estate & Investment Advisors LLC Has $15.74 Million Position in Monsanto Company (MON)
Signature Estate & Investment Advisors LLC grew its stake in Monsanto Company (NYSE:MON) by 6.6% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 132,950 shares of the basic materials company’s stock after buying an additional 8,248 shares during the quarter. Monsanto accounts for about 1.9% of Signature Estate & Investment Advisors LLC’s investment portfolio, making the stock its 20th biggest holding. Signature Estate & Investment Advisors LLC’s holdings in Monsanto were worth $15,736,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors also recently added to or reduced their stakes in the company. Pinnacle Financial Partners Inc. acquired a new position in shares of Monsanto in the second quarter valued at approximately $114,000. Bruderman Asset Management LLC acquired a new position in shares of Monsanto in the second quarter valued at approximately $116,000. Acrospire Investment Management LLC acquired a new position in shares of Monsanto in the first quarter valued at approximately $113,000. Armbruster Capital Management Inc. boosted its holdings in shares of Monsanto by 12.2% in the second quarter. Armbruster Capital Management Inc. now owns 1,147 shares of the basic materials company’s stock valued at $136,000 after buying an additional 125 shares during the period. Finally, JNBA Financial Advisors boosted its holdings in shares of Monsanto by 3.9% in the first quarter. JNBA Financial Advisors now owns 1,193 shares of the basic materials company’s stock valued at $135,000 after buying an additional 45 shares during the period. Institutional investors own 74.80% of the company’s stock.
In other Monsanto news, EVP Steven Mizell sold 11,300 shares of Monsanto stock in a transaction on Monday, July 3rd. The shares were sold at an average price of $118.57, for a total transaction of $1,339,841.00. Following the transaction, the executive vice president now directly owns 55,011 shares of the company’s stock, valued at approximately $6,522,654.27. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Robert T. Fraley sold 52,410 shares of Monsanto stock in a transaction on Monday, July 10th. The stock was sold at an average price of $117.95, for a total transaction of $6,181,759.50. The disclosure for this sale can be found here. In the last three months, insiders sold 89,210 shares of company stock valued at $10,582,280. 0.79% of the stock is currently owned by insiders.
WARNING: This piece was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece on another site, it was copied illegally and republished in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2017/09/30/signature-estate-investment-advisors-llc-has-15-74-million-position-in-monsanto-company-mon.html.
Monsanto Company (NYSE MON) traded up 0.13% during mid-day trading on Friday, reaching $119.82. 2,310,993 shares of the company’s stock traded hands. Monsanto Company has a 12 month low of $97.35 and a 12 month high of $120.00. The company has a 50 day moving average price of $117.37 and a 200-day moving average price of $116.53. The stock has a market cap of $52.64 billion, a P/E ratio of 25.88 and a beta of 1.07.
Monsanto (NYSE:MON) last posted its quarterly earnings results on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.74 by $0.19. Monsanto had a net margin of 14.11% and a return on equity of 45.26%. The business had revenue of $4.23 billion during the quarter, compared to the consensus estimate of $4.18 billion. During the same quarter last year, the firm posted $2.17 EPS. Monsanto’s revenue was up 1.0% compared to the same quarter last year. On average, analysts anticipate that Monsanto Company will post $4.90 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, October 6th will be given a $0.54 dividend. This represents a $2.16 annualized dividend and a yield of 1.80%. The ex-dividend date is Thursday, October 5th. Monsanto’s payout ratio is currently 46.75%.
MON has been the subject of several research analyst reports. Zacks Investment Research upgraded shares of Monsanto from a “hold” rating to a “buy” rating and set a $131.00 price target for the company in a report on Monday, September 4th. BMO Capital Markets reiterated a “buy” rating and issued a $128.00 price target on shares of Monsanto in a report on Friday, September 1st. BidaskClub cut shares of Monsanto from a “hold” rating to a “sell” rating in a report on Sunday, July 16th. Finally, Vetr upgraded shares of Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price target for the company in a report on Wednesday, July 12th. Nine research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Monsanto has a consensus rating of “Hold” and an average target price of $125.53.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.